Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Real-time Estimate Cboe BZX
Other stock markets
 10:38:08 2024-05-21 am EDT 		5-day change 1st Jan Change
2.13 USD +1.43% Intraday chart for Cognition Therapeutics, Inc. +8.08% +15.68%
May. 07 Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Cognition Therapeutics, Inc. Completes Enrollment in Phase 2 SHIMmer Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
COGNITION THERAPEUTICS, INC.
Bio Therapeutic Drugs
+1.90%+8.08%+15.68%-0.93% - 84.12M
Bullish
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. Charts Cognition Therapeutics, Inc.
  5. Comparison Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW